FILE PHOTO: A sign marks the headquarters of Moderna in

FILE PHOTO: A sign marks the headquarters of the coronavirus disease (COVID-19) vaccine maker Moderna in Cambridge, Massachusetts, U.S., April 28, 2022. REUTERS/Brian Snyder/File Photo

Post navigation

Previous: Moderna secures $750 million from Blackstone Life Sciences to develop flu shots

Live Market Pulse

The charting technology is provided by TradingView. Learn how to use theTradingView Stock Screener.

Sign up for our free Bull Bear Daily Newsletter!

Discover new market trends and ideas directly to your inbox.

Search

You may have missed

Newsletters

Wall Street ends narrowly mixed, trading volatile after air strikes on Iran

Bull Bear Daily March 3, 2026

2026-03-02T090953Z_1_LYNXMPEM210GC_RTROPTP_4_SWISS-BANKING-AI.JPG

Newsletters

Safra CEO says Saxo deal shows need for tech scale in AI era

Bull Bear Daily March 3, 2026

2026-03-02T161700Z_1_LYNXMPEM2113G_RTROPTP_4_IRAN-CRISIS-USA-PENTAGON.JPG

Newsletters

Factbox-Top U.S. general outlines initial timeline of U.S. military operation in Iran

Bull Bear Daily March 3, 2026

2026-03-01T200401Z_1_LYNXMPEM2019T_RTROPTP_4_UKRAINE-CRISIS-POLAND-DEFENCE-MINISTERS.JPG

Newsletters

EU nations call for ‘maximum restraint’, respect for international law in Iran conflict

Bull Bear Daily March 2, 2026

Home
Privacy Policy
Terms of Service
Disclaimer
Contact Us

Home
Privacy Policy
Terms of Service
Disclaimer
Contact Us